HIGHLIGHTS
- who: Serena Di Cosimo and colleagues from the Institute Foundation, Scientific Healthcare (IRCCS), Italy Peking University, China have published the paper: End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO, in the Journal: (JOURNAL)
- what: To non-responding patients, and pCR is not always reliable, the authors aimed to challenge circulating miRNAs detected at the end of neoadjuvant therapy as prognostic biomarkers. Consistent with these literature data, the analysis showed that both miR-185-5p and miR146a-5p have a protective prognostic effect, as opposed to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.